Back

New strategies to protect against anthracycline cardiotoxicity

21 June 2025 (14:10 - 14:20)
Organised by: Logo
Congress Presentation Part of: What is new in cardio-oncology research Cardio-Oncology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Professor Doan Ngo

University of Newcastle, Newcastle (Australia)

3 More presentations in this session

Presentation thumbnail
Crosstalk between the heart and cancer
Professor R. De Boer (Rotterdam, NL)
Slides Video
Presentation thumbnail
Imaging of cancer treatment-related cardiovascular toxicity
Professor B. Ibanez (Madrid, ES)
Slides Video
Presentation thumbnail
What is new in cardio-oncology research - discussion
Video

Access the full session

Session thumbnail
What is new in cardio-oncology research

The Event

Event poster

ESC Cardio-Oncology 2025

21 June 2025 14:10 CET
You may be interested in
thumbnail
Congress Session
Translational frontiers in cardio-oncology
19 June 2026
thumbnail
Congress Presentation
The clinically active PARP inhibitor olaparib ameliorates doxorubicin-induced cardiotoxicity in both in vitro and in vivo model
26 August 2023
thumbnail
Congress Presentation
Dexrazoxane and liposomal anthracyclines
20 June 2025
thumbnail
Congress Presentation
Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources